BMIR Research In Progress: Francesco Vallania "ImmunoStates: A New Strategy for Accurate Cell Mixture Deconvolution Across Multiple Gene Expression Platforms and Sample Types" @ MSOB, Conference Room X-275 | Stanford | California | United States
Francesco Vallania Postdoctoral Scholar Khatri Lab, Stanford University Abstract: Cell-mixture deconvolution is an in silico strategy that quantifies proportions of multiple cell subsets directly from gene expression of mixed-cell samples using a signature matrix to link[...]
BMIR Research in Progress: Edward H. Lee “A Deep Learning Framework to Predict Survival from Medical Images of Lung Cancer Patients” @ MSOB, Conference Room X-275 | Stanford | California | United States
Edward H. Lee Graduate Student Gevaert Lab, Stanford University We present a deep learning framework to predict survival of lung cancer patients by using convolutional networks to learn high-dimensional representations of tumor phenotypes from CT[...]
BMIR Research in Progress: Mu Zhou“Radiogenomics: Linking Molecular Data and Clinical Imaging Towards Non-invasive Precision Oncology” @ MSOB | Stanford | California | United States
  Mu Zhou Postdoctoral Scholar BMIR, Stanford University ABSTRACT: Growing amounts of molecular data and clinical imaging arrays offer opportunities to gain insights into translational cancer research. Exploring the interplay between these heterogeneous cancer data[...]
BMIR Research Colloquium: Teri Klein "Pharmacogenomics Knowledge for Personalized Medicine" @ MSOB, Conference Room X-275 | Stanford | California | United States
Teri Klein Member of Academic Council Professor (Research) of Biomedical Data Science and of Medicine (BMIR) Stanford University Abstract: Pharmacogenomics (PGx) focuses on the use of genomic information to guide drug therapy and is a[...]
BMIR Research in Progress: Pritam Mukherjee "Early Detection of Cancer in the NLST Dataset" @ MSOB  | Stanford | California | United States
Pritam Mukherjee, Postdoctoral Scholar, BMIR, Stanford University ABSTRACT: The National Lung Screening Trial (NLST) screened high risk individuals, heavy smokers and between the age of 55 and 74 years, for lung cancer, using either low[...]